Candriam SCA’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-106,369
| Closed | -$9.04M | – | 868 |
|
|
2020
Q3 | $9.04M | Sell |
106,369
-1,022,263
| -91% | -$86.9M | 0.09% | 256 |
|
|
2020
Q2 | $40M | Buy |
1,128,632
+591,558
| +110% | +$21M | 0.42% | 49 |
|
|
2020
Q1 | $11.1M | Buy |
537,074
+37
| +0% | +$765 | 0.12% | 192 |
|
|
2019
Q4 | $11.4M | Buy |
537,037
+47,737
| +10% | +$1.01M | 0.12% | 194 |
|
|
2019
Q3 | $6.49M | Sell |
489,300
-241,100
| -33% | -$3.2M | 0.09% | 268 |
|
|
2019
Q2 | $10.1M | Sell |
730,400
-205,487
| -22% | -$2.84M | 0.13% | 188 |
|
|
2019
Q1 | $18M | Buy |
935,887
+39,511
| +4% | +$759K | 0.23% | 98 |
|
|
2018
Q4 | $12.8M | Sell |
896,376
-869,124
| -49% | -$12.4M | 0.2% | 120 |
|
|
2018
Q3 | $36.8M | Buy |
1,765,500
+1,027,500
| +139% | +$21.4M | 0.49% | 40 |
|
|
2018
Q2 | $17.5M | Buy |
738,000
+141,000
| +24% | +$3.34M | 0.28% | 85 |
|
|
2018
Q1 | $8.72M | Buy |
597,000
+42,000
| +8% | +$614K | 0.15% | 179 |
|
|
2017
Q4 | $8.97M | Buy |
555,000
+60,500
| +12% | +$978K | 0.16% | 168 |
|
|
2017
Q3 | $6.91M | Sell |
494,500
-55,500
| -10% | -$776K | 0.12% | 210 |
|
|
2017
Q2 | $4.86M | Buy |
550,000
+40,000
| +8% | +$353K | 0.09% | 268 |
|
|
2017
Q1 | $3.3M | Buy |
+510,000
| New | +$3.3M | 0.06% | 348 |
|
|
2016
Q3 | – | Sell |
-185,000
| Closed | -$429K | – | 684 |
|
|
2016
Q2 | $429K | Buy |
+185,000
| New | +$429K | 0.01% | 579 |
|
|
2015
Q3 | – | Sell |
-330,000
| Closed | -$1.34M | – | 655 |
|
|
2015
Q2 | $1.34M | Sell |
330,000
-195,000
| -37% | -$792K | 0.03% | 408 |
|
|
2015
Q1 | $2.01M | Sell |
525,000
-100,000
| -16% | -$383K | 0.04% | 385 |
|
|
2014
Q4 | $3M | Buy |
+625,000
| New | +$3M | 0.06% | 307 |
|